Month December 2024

Tharimmune secures $2.02 million in personal funding

BRIDGEWATER, NEW JERSEY – Tharimmune, Inc. (NASDAQ:THAR), a biotech agency specializing in immunology and irritation with a market capitalization of $3.02 million, has introduced a personal placement deal to boost roughly $2.02 million. The corporate’s inventory has declined over 60%…

What do Trump 2.0 tariffs imply for US retailers?

Investing.com — Bernstein analysts on Tuesday highlighted potential tariff dangers for main US retailers in mild of President-elect Trump’s dedication to impose tariffs on imports from Canada, Mexico, and China. Among the many retailers, Greenback Tree (NASDAQ:DLTR) and Goal (NYSE:TGT)…